Search Results - "Arlene M. Buller"
-
1
Annotation error of a common β°‐thalassemia mutation (619 bp‐deletion) has implications for molecular diagnosis
Published in American journal of hematology (01-12-2010)Get full text
Journal Article -
2
The challenge of using SNPs in the understanding and treatment of disease
Published in BioTechniques (01-06-2002)Get full text
Journal Article -
3
Higher detection rate of JAK2 mutation using plasma
Published in Blood (01-04-2008)Get full text
Journal Article -
4
Development of Genomic Reference Materials for Cystic Fibrosis Genetic Testing
Published in The Journal of molecular diagnostics : JMD (01-05-2009)“…The number of different laboratories that perform genetic testing for cystic fibrosis is increasing. However, there are a limited number of quality control and…”
Get full text
Journal Article -
5
Development of a Genomic DNA Reference Material Panel for Rett Syndrome ( MECP2 -Related Disorders) Genetic Testing
Published in The Journal of molecular diagnostics : JMD (01-03-2014)“…Rett syndrome is a dominant X-linked disorder caused by point mutations (approximately 80%) or by deletions or insertions (approximately 15% to 18%) in the…”
Get full text
Journal Article -
6
-
7
Secondary Mutation (c.94_95delAG) in A −α3.7 Allele Associated with Hb H Disease in Two Unrelated African American Individuals Homozygous for the −α3.7 Deletion (−α3.7/−α3.7T)
Published in Hemoglobin (01-02-2012)“…Hb H disease is rarely seen in individuals of African descent although α-thalassemia (α-thal) is common in this population. Usually α-thal is due either to…”
Get full text
Journal Article -
8
The Roles of 5â²-HS2, 5â²-HS3, and the γ-Globin TATA, CACCC, and Stage Selector Elements in Suppression of β-Globin Expression in Early Development
Published in The Journal of biological chemistry (16-04-1999)“…The roles of HS2 and HS3 from the human β-globin locus control region and of the TATA, CACCC, and stage selector elements of the γ-globin promoter, in…”
Get full text
Journal Article -
9
The roles of 5'-HS2, 5'-HS3, and the gamma-globin TATA, CACCC, and stage selector elements in suppression of beta-globin expression in early development
Published in The Journal of biological chemistry (16-04-1999)“…The roles of HS2 and HS3 from the human beta-globin locus control region and of the TATA, CACCC, and stage selector elements of the gamma-globin promoter, in…”
Get full text
Journal Article -
10
Secondary mutation (c.94_95delAG) in a -α3.7 allele associated with Hb H disease in two unrelated African American individuals homozygous for the -α(3.7) deletion (-α3.7/-α3.7T)
Published in Hemoglobin (2012)“…Hb H disease is rarely seen in individuals of African descent although α-thalassemia (α-thal) is common in this population. Usually α-thal is due either to…”
Get full text
Journal Article -
11
A Combination of Hydroxyurea and Isobutyramide to Induce Fetal Hemoglobin in Transgenic Mice Is More Hematotoxic Than the Individual Agents
Published in Blood cells, molecules, & diseases (01-08-1999)“…Pharmacologic agents such as hydroxyurea (HU), N, 3–4 trihydroxybenzamide (didox), and isobutyramide (ISB) can elevate γ-globin as a potential treatment for…”
Get full text
Journal Article -
12
The gamma-globin promoter has a major role in competitive inhibition of beta-globin gene expression in early erythroid development
Published in DNA and cell biology (01-04-1999)“…The human gamma-globin gene competitively inhibits beta-globin gene expression in early erythroid development. To identify the gamma-globin gene sequences…”
Get more information
Journal Article -
13
Genetic changes in solid tumors
Published in Seminars in surgical oncology (01-06-2000)“…Although most solid tumors are treated surgically, determining the genetic changes present in the tumor of an individual patient is becoming increasingly…”
Get full text
Journal Article -
14